Morse v. Merit Sys. Prot. Bd., 10-3030, involved a plaintiff’s action claiming that the Transportation Security Administration violated his veterans’ preference rights when it declined to waive its maximum entry age requirement in connection with his application for employment as a Federal Air Marshal.  In affirming the Merit Systems Protection Board’s dismissal for lack of jurisdiction, the court held that the TSA is exempt from section 3330(a) of Title 5, which provides Board appeal rights for preference eligible veterans.

 

Eli Lilly & Co. v. Teva Pharm. USA, Inc., 10-1005, involved a patent infringement suit related to a drug for postmenopausal osteoporosis.  In affirming the judgment of the district court, the court held that the record amply supports the district court’s conclusion that the ordinary artisan would not have considered it obvious to use raloxifene to treat postmenopausal osteoporosis.  Also, because the district court’s conclusion that the Bone Loss Patents would not have been obvious, its conclusion as to the Low Dose Patent is affirmed as well.  The court also held that the district court did not err in concluding that the Bone Loss Patents and the Low Dose Patents were not invalid for lack of enablement, nor in invalidating the asserted claims of the Particle Size Patents for lack of written description.

Related Resources:

  • Full text of Eli Lilly & Co. v. Teva Pharm. USA, Inc., 10-1005
  • Full text of Funai Elec. Co., Ltd. v. Daewoo Elec. Corp., 09-1225
  • Full text of Morse v. Merit Sys. Prot. Bd., 10-3030

You Don’t Have To Solve This on Your Own – Get a Lawyer’s Help

Civil Rights

Block on Trump’s Asylum Ban Upheld by Supreme Court

Criminal

Judges Can Release Secret Grand Jury Records

Politicians Can’t Block Voters on Facebook, Court Rules